首页|补肾活血方联合雌二醇片/雌二醇地屈孕酮片对卵巢早衰患者中医证候、卵巢储备功能及T细胞亚群的影响

补肾活血方联合雌二醇片/雌二醇地屈孕酮片对卵巢早衰患者中医证候、卵巢储备功能及T细胞亚群的影响

扫码查看
目的:探讨补肾活血方联合雌二醇片/雌二醇地屈孕酮片治疗卵巢早衰(POF)患者的临床疗效及对患者中医证候积分、卵巢储备功能及T细胞亚群的影响.方法:选取2020年12月~2022年6月期间于某院就诊的90例POF患者作为研究对象,采用随机数字表法分为西药组、中药组和联合组,每组30例.西药组患者给予雌二醇片/雌二醇地屈孕酮片复合包装治疗,中药组患者给予补肾活血方治疗,联合组患者给予补肾活血方联合雌二醇片/雌二醇地屈孕酮片复合包装治疗,均治疗3个疗程.比较三组患者中医证候积分、性激素水平[促卵泡激素(FSH)、黄体生成素(LH)、雌二醇(E2)]、卵巢储备功能(子宫内膜厚度、窦卵泡数量、卵巢体积)、T细胞亚群(CD3+、CD4+、CD8+)、临床疗效及不良反应发生情况.结果:治疗后,三组患者中医证候积分均降低(P<0.05),且联合组低于西药组和中药组(P<0.05);FSH和LH水平均降低(P<0.05),且联合组低于西药组和中药组(P<0.05);E2 水平均升高(P<0.05),且联合组高于西药组和中药组(P<0.05);子宫内膜厚度、窦卵泡数量、卵巢体积均增加(P<0.05),且联合组高于西药组和中药组(P<0.05);CD3+和CD8+均降低(P<0.05),且联合组低于西药组和中药组(P<0.05);CD4+均升高(P<0.05),且联合组高于西药组和中药组(P<0.05).联合组患者治疗总有效率(90.00%)高于西药组(60.00%)和中药组(76.67%,P<0.05).三组患者服药期间均未发生明显不良反应.结论:补肾活血方联合雌二醇片/雌二醇地屈孕酮片治疗POF患者临床疗效较佳,可有效缓解POF患者临床症状,改善性激素水平、卵巢储备功能和免疫功能.
Effects of Bushen Huoxue Formula Combined with Estradiol Tablets/Estradiol and Dydrogesterone Tablets on Traditional Chinese Medicine Syndrome,Ovarian Reserve Function and T Cell Subsets in Patients with Premature Ovarian Failure
Objective:To investigate the clinical efficacy of Bushen Huoxue formula combined with estradiol tablets/estradiol and dydrogesterone tablets in the treatment of premature ovarian failure(POF)and its effects on traditional Chinese medicine(TCM)syndrome scores,ovarian reserve function and T cell subsets.Methods:A total of 90 patients with POF who visited a hospital from December 2020 to June 2022 were selected and divided into the western medicine group,TCM group and combination group by random number table method,with 30 patients in each group.The western medicine group was treated with complex packing estradiol tablets/estradiol and dydrogesterone tablets,the TCM group with Bushen Huoxue formula,and the combination group with Bushen Huoxue formula combined with complex packing estradiol tablets/estradiol and dydrogesterone tablets.All groups were treated for 3 cycles.The TCM syndrome scores,sex hormone levels[follicle-stimulating hormone(FSH),luteinizing hormone(LH),estradiol(E2)],ovarian reserve function(endometrial thickness,antral follicle count,ovarian volume),T cell subsets(CD3+,CD4+,CD8+),clinical response and adverse reactions were compared among the three groups.Results:After treatment,the TCM syndrome scores were decreased in both groups(P<0.05),and were lower in the combination group than those in the other two groups(P<0.05).The levels of FSH and LH were decreased in both groups(P<0.05),and were lower in the combination group than those in the other two groups(P<0.05).The level of E2 was increased in both groups(P<0.05),and was higher in the combination group than that in the other two groups(P<0.05).Endometrial thickness,antral follicle count and ovarian volume were increased in both groups(P<0.05),and were higher in the combination group than those in the other two groups(P<0.05).The levels of CD3+and CD8+were decreased in both groups(P<0.05),and were lower in the combination group than those in the other two groups(P<0.05).The level of CD4+was increased in both groups(P<0.05),and was higher in the combination group than that in the other two groups(P<0.05).The total response rate in the combination group(90.00%)was higher as compared with the western medicine(60.00%)and the TCM groups(76.67%,P<0.05).No significant adverse reactions were observed in any of the three groups during the treatment.Conclusion:Bushen Huoxue formula combined with estradiol tablets/estradiol and dydrogesterone tablets has satisfactory clinical efficacy in the treatment of patients with POF as demonstrated by effectively relieved clinical symptoms and improved sex hormone levels,ovarian reserve function and immune function.

premature ovarian failureBushen Huoxue formulaestradiol tablets/estradiol and dydrogesterone tabletstraditional Chinese medicine syndromeovarian reserve functionT cell subsets

董亚兰、张晟、余健秋、王瑞敏

展开 >

信阳市中心医院中医科,信阳 464000

卵巢早衰 补肾活血方 雌二醇片/雌二醇地屈孕酮片 中医证候 卵巢储备功能 T细胞亚群

河南省医学科技攻关计划项目

LHGJ20201059

2024

中国合理用药探索
中国执业药师协会

中国合理用药探索

影响因子:0.62
ISSN:2096-3327
年,卷(期):2024.21(7)